People living with ALS, family members, friends, caregivers and anyone affected by the disease will come together for the ...

Scientists in Scotland discovered medications, which target specific receptors, may be therapeutic for diseases that lead to ...

Athira Pharma has been on a bumpy road in recent years, and, now, the company is restructuring and shedding weight to try to keep the journey going.  | Just a couple of weeks after announcing that its ...

Utah's life sciences sector is a significant economic powerhouse, but the misguided the Medication Affordability and Patent ...

Drugs that switch on vitamin A in the body may also help stave off conditions such as motor neurone disease (MND), raising hopes of new treatments, research suggests. Scientists found drugs which ...

The CEO Soak is on Thursday, Sept. 19 from 1 p.m. - 3 p.m. in St. Petersburg. People can sign up for the cause and help raise ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Discover promising biotech candidates and groundbreaking research offering new hope for treating mitochondrial diseases.

A no vote on Prop 34. is a vote to keep rules governing California-based participants in the federal drug discount program ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

The biopharmaceutical company is focusing on a new drug after releasing disappointing data from an Alzheimer's drug earlier ...

ATH-1105 is an orally delivered, positive modulator of the neurotrophic HGF system that is currently in a Phase 1 clinical trial with completion ...